Assessing the global burden of hemorrhage: The global blood supply, deficits, and potential solutions

SAGE Open Medicine

Volumn 9, Issue , 2021, Pages

  Raykar, Nakul P ^a,b   Makin, Jennifer ^c   Khajanchi, Monty ^d   Olayo, Bernard ^e   Munoz Valencia, Alejandro ^b   Roy, Nobhojit ^d,f   Ottolino, Pablo ^g   Zinco, Analia ^g   MacLeod, Jana ^b,h   Yazer, Mark ^b   Rajgopal, Jayant ⁱ   Zeng, Bo ⁱ   Lee, Hyo Kyung ⁱ   Bidanda, Bopaya ⁱ   Kumar, Pratap ^h   Puyana, Juan Carlos ^b   Rudd, Kristina ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d KEM HOSPITAL   (India)

^e African Institute for Health and Development   (Kenya)

^f Universidad Católica ^*  (India)

^g PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^h STRATHMORE UNIVERSITY   (Kenya)

ⁱ University of Pittsburgh   (United States)

Author keywords

blood transfusion; Global blood availability; global surgery; unbanked directed blood transfusion; walking blood banks

Indexed keywords

HEMOGLOBIN; IRON;

ANEMIA; AWARENESS; BLEEDING; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD GROUP; BLOOD GROUP SYSTEM; BLOOD SAMPLING; BLOOD STORAGE; BLOOD TRANSFUSION; CHAGAS DISEASE; CHIKUNGUNYA VIRUS; DECISION MAKING; DENGUE; DENGUE VIRUS; DENTAL PROCEDURE; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC SHOCK; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS E VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; IMMUNOGENICITY; INJURY; MALARIA; MORBIDITY; MORTALITY; NONHUMAN; OBSTETRIC HEMORRHAGE; PLASMA; PREVALENCE; QUALITY CONTROL; QUESTIONNAIRE; REFRIGERATION; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROPREVALENCE; SOCIAL MEDIA; SYPHILIS; SYSTEMATIC REVIEW; THROMBOCYTE; TRYPANOSOMA CRUZI; ULTRAVIOLET RADIATION; VASCULARIZATION; WEST NILE VIRUS; ZIKA VIRUS;

EID: 85118981242     PISSN: None     EISSN: 20503121     Source Type: Journal    
DOI: 10.1177/20503121211054995     Document Type: Review

References (92)

1. Vos T Allen C Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388(10053): 1545–1602.
2. Roth GA Abate D Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392(10159): 1736–1788.
3. Tran N Breene J Khayesi M, et al. WHO global status report on road safety: Report from the World Health Organization. Geneva: WHO, 2018.
4. Baraniuk S Tilley BC del Junco DJ, et al. Pragmatic Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial: design, rationale and implementation. Injury 2014; 45(9): 1287–1295.
5. Ashigbie P Tanna S. WHO background paper 6.16 on postpartum haemorrhage: report from the World Health Organization. Geneva: WHO, 2013.
6. Kiguli S Maitland K George EC, et al. Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness. BMC Med 2015; 13(1): 21.
7. Scott S Chen-Edinboro L Murray-Kolb L. The impact of anemia on child mortality. Nutrients 2014; 6(12): 5915–5932.
8. World Health Organization. WHO global status report on blood safety and availability 2016: report from World Health Organization. Geneva: WHO, 2017.
9. Roberts N James S Delaney M, et al. The global need and availability of blood products: a modelling study. Lancet Haematol 2019; 6: E606–E615.
10. Chargé S. Vein to vein: a summary of the blood system in Canada. Canadian Blood Transfusion Services 2019, https://professionaleducation.blood.ca/en/transfusion/clinical-guide/vein-vein-summary-blood-system-canada
11. WHO blood donor selection guidelines on assessing donor suitability for blood donation: report from the World Health Organization. Geneva: WHO, 2012.
12. Longo DL Carson JL Triulzi DJ, et al. Indications for and adverse effects of red-cell transfusion. N Engl J Med 2017; 13: 1261–1272.
13. Moncayo Silveira AC. Current epidemiological trends of Chagas disease in Latin America and future challenges: epidemiology, surveillance, and health policies. In: Telleria J Tibayrenc M (eds) American trypanosomiasis chagas disease: one hundred years of research. 2nd ed. Amsterdem: Elsevier, 2017. pp. 59–88.
14. Field SP Allain J-P. Transfusion in sub-Saharan Africa: does a Western model fit. J Clin Pathol 2007; 60(10): 1073–1075.
15. Supply of blood for transfusion in Latin American and Caribbean countries 2010 and 2011: report from the Pan American Health Organization. Washington, DC: Pan American Health Organization, 2013.
16. Balarajan Y Ramakrishnan U Özaltin E, et al. Anaemia in low-income and middle-income countries. Lancet 2011; 378(8): 2123–2135.
17. Jung J Rahman M Rahman S, et al. Effects of hemoglobin levels during pregnancy on adverse maternal and infant outcomes: a systematic review and meta-analysis. Ann N Y Acad Sci 2019; 1450: 69–82.
18. Global health sector strategy on viral hepatitis 2016–2021: report from the World Health Organization. Geneva: WHO, 2016.
19. Tagny C Diarra A Yahaya R, et al. The transfusion center, the blood donor and the given blood in francophone African countries. Transfus Clin Biol 2009; 16: 431–438.
20. Owusu-Ofori AK Parry C Bates I. Transfusion-transmitted Malaria in countries where Malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis 2010; 51: 1192–1198.
21. Agnihotri N. Whole blood donor deferral analysis at a center in Western India. Asian J Transfus Sci 2010; 4: 116–122.
22. Aneke C Ezeh U Nwosu A, et al. Retrospective evaluation of prospective blood donor deferral in a tertiary hospital-based blood bank in South-East Nigeria. J Med Tropics 2016; 18: 103–107.
23. Mast AE. Low hemoglobin deferral in blood donors. Transfus Med Rev 2014; 28: 18–22.
24. Smith GA Fisher SA Dorée C, et al. A systematic review of factors associated with the deferral of donors failing to meet low haemoglobin thresholds. Transfus Med 2013; 13: 309–320.
25. Geissler PW. “Kachinja are coming!”: encounters around medical research work in a Kenyan village. Afr J Int African Inst 2005; 75: 173–202.
26. Lownik E Riley E Konstenius T, et al. Knowledge, attitudes and practices surveys of blood donation in developing countries. Vox Sang 2012; 103: 64–74.
27. Dubey A Sonker A Chaurasia R, et al. Knowledge, attitude and beliefs of people in North India regarding blood donation. Blood Transfus 2014; 12(Suppl. 1): S21–S27.
28. Bates I Manyasi G Medina Lara A. Reducing replacement donors in sub-Saharan Africa: challenges and affordability. Transfus Med 2007; 17: 434–442.
29. Kyeyune-Byabazaire D Hume HA. Towards a safe and sufficient blood supply in sub-Saharan Africa. ISBT Sci 2019; 14: 104–113.
30. Zou S Dorsey KA Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010; 50: 1495–1504.
31. Stramer SL Notari EP Krysztof DE, et al. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety. Transfusion 2013; 53(10 Pt. 2): 2449–2458.
32. Jayaraman S Chalabi Z Perel P, et al. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 2010; 50: 443–442.
33. Busch MP Bloch EM Kleinman S. Prevention of transfusion-transmitted infections. Blood 2019; 133: 1854–1864.
34. Prugger C Laperche S Murphy EL, et al. Screening for transfusion transmissible infections using rapid diagnostic tests in Africa: a potential hazard to blood safety. Vox Sang 2016; 110: 196–198.
35. Laperche S Boukatou G Kouegnigan L, et al. Transfusion safety on the African continent: an international quality control of virus testing in blood banks. Transfusion 2009; 49: 1600–1608.
36. Guidelines on Hepatitis B and C testing: report from the World Health Organization. Geneva: WHO, 2017.
37. Tagny CT Diarra A Yahaya R, et al. Characteristics of blood donors and donated blood in sub-Saharan Francophone Africa. Transfusion 2009; 49: 1592–1599.
38. Developing a national policy and guidelines on the clinical use of blood recommendations: report from the World Health Organization. Geneva: WHO, 2001.
39. Moore A Herrera G Nyamongo J, et al. Estimated risk of HIV transmission by blood transfusion in Kenya. Lancet 2001; 358: 657–660.
40. Butler EK Hume H Birungi I, et al. Blood utilization at a national referral hospital in sub-Saharan Africa. Transfusion 2015; 55(5): 1058–1066.
41. Javadzadeh Shahshahani H Taghvai N. Blood wastage management in a regional blood transfusion centre. Transfus Med 2017; 27: 348–353.
42. Carson JL Guyatt G Heddle NM, et al. Clinical practice guidelines from the AABB. JAMA 2016; 316: 2025–2035.
43. Sood R Yorlets RR Raykar NP, et al. The global surgery blood drought: frontline provider data on barriers and solutions in Bihar, India. Glob Health Action 2019; 12: 1599541.
44. Apata I Drammeh B De A, et al. Diagnoses and ordering practices driving blood demand for treatment of anemia in Tanzania. Transfusion 2018; 58: 379–389.
45. Galloway R McGuire J. Determinants of compliance with iron supplementation: supplies, side effects, or psychology? Soc Sci Med 1994; 39: 381–390.
46. Ndiaye M Siekmans K Haddad S, et al. Impact of a positive deviance approach to improve the effectiveness of an iron-supplementation program to control nutritional anemia among rural Senegalese pregnant women. Food Nutr Bull 2009; 30: 128–136.
47. Uma S Arun R Arumugam P. The knowledge, attitude and practice towards blood donation among voluntary blood donors in Chennai, India. J Clin Diagn Res 2013; 7: 1043–1046.
48. Rodrigues Da Silva J César C Brasil P, et al. MHealth technology as a tool to promote blood donation, 2018, https://www.scitepress.org/Papers/2018/65978/65978.pdf
49. Sardi L Idri A Fernández-Alemán JL. Gamified mobile blood donation applications. In: Rojas I Ortuño F (eds) Computer science, artificial intelligence, bioinformatics. Cham: Springer, 2017, pp. 165–176.
50. Mews M. To pay or not to pay: the role of monetary incentives in an optimal blood donation service bundle. Int J Nonp Volunt Sect 2013; 18: 192–202.
51. Weidmann C Schneider S Litaker D, et al. A spatial regression analysis of German community characteristics associated with voluntary non-remunerated blood donor rates. Vox Sang 2012; 102: 47–54.
52. Healy K. Embedded altruism: blood collection regimes and the European Union’s donor population. Am J Sociol 2000; 105: 1633–1657.
53. Copeman J. Veins of devotion: blood donation and religious experience in North India. New Brunswick, NJ: Rutgers University Press, 2009.
54. Shenga N Pal R Sengupta S. Behavior disparities towards blood donation in Sikkim, India. Asian J Transfus Sci 2008; 2: 56–60.
55. Chell K Davison TE Masser B, et al. A systematic review of incentives in blood donation. Transfusion 2018; 58: 242–254.
56. Godin G Vézina-Im L-A Bélanger-Gravel A, et al. Efficacy of interventions promoting blood donation: a systematic review. Transfus Med Rev 2012; 26: 224.e–237.e6.
57. Reich P Roberts P Laabs N, et al. A randomized trial of blood donor recruitment strategies. Transfusion 2006; 46: 1090–1096.
58. Garbarino E Heger S Wang C, et al. Redesigning the market for volunteers: a Donor Registry. Association for Consumer Research, 2017, http://www.acrwebsite.org/volumes/1023880/volumes/v45/NA-45http://www.copyright.com/
59. Tagny CT Nguefack-Tsague G Fopa D, et al. Risk factors for human immunodeficiency virus among blood donors in Cameroon: evidence for the design of an Africa-specific donor history questionnaire. Transfusion 2017; 57: 1912–1921.
60. Makroo RN Choudhury N Jagannathan L, et al. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 & hepatitis B & C viruses in Indian blood donors. Ind J Med Res 2008; 127: 140–147.
61. Busch MP Glynn SA Stramer SL, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254–264.
62. Gous N Scott L Perovic O, et al. Should South Africa be performing nucleic acid testing on HIV enzyme-linked immunosorbent assay-negative samples. J Clin Microbiol 2010; 48: 3407–3409.
63. Jain R Aggarwal P Gupta GN. Need for nucleic acid testing in countries with high prevalence of transfusion-transmitted infections. ISRN Hematol 2012; 2012: 718671.
64. El Ekiaby M Lelie N Allain JP. Nucleic acid testing (NAT) in high prevalence–low resource settings. Biologicals 2010; 38: 59–64.
65. Safic Stanic H Babic I Maslovic M, et al. Three-year experience in NAT screening of blood donors for transfusion transmitted viruses in Croatia. Transfus Med Hemother 2017; 44: 415–420.
66. Katz LM Donnelly JJ Gresens CJ, et al. Report of a workshop on ensuring sustainable access to safe blood in developing countries: International Blood Safety Forum, March 24, 2017. Transfusion 2018; 58(5): 1299–1306.
67. Farrugia A Penrod J Bult JM. The ethics of paid plasma donation: a plea for patient centeredness. HEC Forum 2015; 27: 417–429.
68. Allain J-P. Moving on from voluntary non-remunerated donors: who is the best blood donor. Br J Haematol 2011; 154: 763–769.
69. Pruett C Vermeulen M Zacharias P, et al. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review. Transfus Med Rev 2015; 29: 35–44.
70. Seltsam A. Pathogen inactivation of cellular blood products: an additional safety layer in transfusion medicine. Front Med 2017; 4: 219.
71. Marwaha N Sachdev S. Current testing strategies for hepatitis C virus infection in blood donors and the way forward. World J Gastroenterol 2014; 20: 2948–2954.
72. Allain J-P Goodrich RP Owusu-Ofori AK, et al. Effect of plasmodium inactivation in whole blood on the incidence of blood transfusion-transmitted malaria in endemic regions: the African Investigation of the Mirasol System (AIMS) randomized controlled trial. Lancet 2016; 387: 1753–1761.
73. Butler EK McCullough J. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda. Transfusion 2018; 58: 854–861.
74. Ifland L Bloch EM Pitman JP. Funding blood safety in the 21st century. Transfusion 2018; 58: 105–112.
75. Ala F Allain J-P Bates I, et al. External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med 2012; 9: e1001309.
76. Yazer MH Cap AP Spinella PC. How do I implement a whole blood program for massively bleeding patients. Transfusion 2018; 58: 622–628.
77. Yazer MH Jackson B Sperry JL, et al. Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg 2016; 81: 21–26.
78. Yao K Maruta T Luman ET, et al. The SLMTA programme: transforming the laboratory landscape in developing countries. Afr J Lab Med 2014; 3: 194.
79. Eno LT Asong T Ngale E, et al. Driving hospital transformation with SLMTA in a regional hospital in Cameroon. Afr J Lab Med 2014; 3: 221.
80. Pirabán A Guerrero WJ Labadie N. Survey on blood supply chain management: models and methods. Comput Oper Res 2019; 112: 104756.
81. Scott JE Scott CH. Drone delivery models for healthcare. Int J Syst Sci 2017; 2017: 3297–3304.
82. Glauser W. Blood-delivering drones saving lives in Africa and maybe soon in Canada. Can Med Assoc J 2018; 190: E88–E89.
83. Mahoha GA Mwanda WO Afulo OK. Autologous transfusion in surgical patients at Kenyatta National Hospital, Nairobi. East Afr Med J 2001; 78: 546–567.
84. Sjoholm A Alga A von Schreeb J. A last resort when there is no blood: experiences and perceptions of intraoperative autotransfusion among medical doctors deployed to resource-limited settings. World J Surg 2020; 44: 4052–4059.
85. Spence RK Erhard J. History of patient blood management. Best Pract Res: Clin Anaesthesiol 2013; 27: 11–15.
86. Sienko KH Young MR Kaufmann EE, et al. Global health design: clinical immersion, opportunity identification and definition, and design experiences authors. Int J Eng Educ 2018; 34: 780–800.
87. Charles KS Friday M Lall D, et al. A university: led initiative to promote voluntary non-remunerated blood donation in a developing country. Transfus Apher Sci 2019; 58: 674–679.
88. Maghsudlu M. Keys to move to self-sufficiency in safe blood components based on voluntary blood donation. ISBT Sci 2017; 12: 202–206.
89. Flanagan P. Blood donation: incentives and inducements—where to draw the line? ISBT Sci 2019; 15: 19–22.
90. Sood R Raykar N Till B, et al. Walking blood banks: an immediate solution to rural India’s blood drought. Indian J Med Ethics 2018; 3: 134–137.
91. Chandler MH Roberts M Sawyer M, et al. The US military experience with fresh whole blood during the conflicts in Iraq and Afghanistan. Semin Cardiothorac Vasc Anesth 2012; 16: 153–159.
92. Bassett AK Auten JD Zieber TJ, et al. Early, prehospital activation of the walking blood bank based on mechanism of injury improves time to fresh whole blood transfusion. J Spec Oper Med 2016; 16: 5–8.